These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38758224)

  • 21. Recommendations on deprescribing of bisphosphonates in osteoporosis guidelines: a systematic review.
    Jepsen DB; Bergen ES; Pan J; van Poelgeest E; Osman A; Burghle A; Ryg J; Thompson W; Lundby C
    Eur Geriatr Med; 2023 Aug; 14(4):747-760. PubMed ID: 37393587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revisiting systematic reviews on deprescribing trials to better inform future practice and research.
    Spinewine A; Reeve E; Thompson W
    Br J Clin Pharmacol; 2023 Dec; 89(12):3758-3764. PubMed ID: 37522371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Health Care Organization - The New German S3-Guideline on Alcohol-Related Disorders and its Relevance for Health Care].
    Günthner A; Weissinger V; Fleischmann H; Veltrup C; Jäpel B; Längle G; Amann K; Hoch E; Mann K
    Rehabilitation (Stuttg); 2018 Oct; 57(5):314-320. PubMed ID: 29359282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Challenges and current approaches in the development of psychiatric living guidelines in Germany].
    Pfennig A; Soltmann B; Riedel-Heller SG; Gühne U; Jessen F; Bauer M; Schmitt J
    Nervenarzt; 2023 Jul; 94(7):587-593. PubMed ID: 37311964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guideline compliance in the treatment of schizophrenic patients. Introduction of a computer-assisted treatment pathway].
    Godemann F; Blittersdorf K; Poschenrieder M; Klimitz H; Hauth I; Gutzmann H
    Nervenarzt; 2010 May; 81(5):584-93. PubMed ID: 20024526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evidence-based therapy of depression: S3 guidelines on unipolar depression].
    Härter M; Klesse C; Bermejo I; Bschor T; Gensichen J; Harfst T; Hautzinger M; Kolada C; Kopp I; Kühner C; Lelgemann M; Matzat J; Meyerrose B; Mundt C; Niebling W; Ollenschläger G; Richter R; Schauenburg H; Schulz H; Weinbrenner S; Schneider F; Berger M
    Nervenarzt; 2010 Sep; 81(9):1049-68. PubMed ID: 20802992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations for outcome measurement for deprescribing intervention studies.
    Bayliss EA; Albers K; Gleason K; Pieper LE; Boyd CM; Campbell NL; Ensrud KE; Gray SL; Linsky AM; Mangin D; Min L; Rich MW; Steinman MA; Turner J; Vasilevskis EE; Dublin S
    J Am Geriatr Soc; 2022 Sep; 70(9):2487-2497. PubMed ID: 35648465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients.
    Anderson-Schmidt H; Adler L; Aly C; Anghelescu IG; Bauer M; Baumgärtner J; Becker J; Bianco R; Becker T; Bitter C; Bönsch D; Buckow K; Budde M; Bührig M; Deckert J; Demiroglu SY; Dietrich D; Dümpelmann M; Engelhardt U; Fallgatter AJ; Feldhaus D; Figge C; Folkerts H; Franz M; Gade K; Gaebel W; Grabe HJ; Gruber O; Gullatz V; Gusky L; Heilbronner U; Helbing K; Hegerl U; Heinz A; Hensch T; Hiemke C; Jäger M; Jahn-Brodmann A; Juckel G; Kandulski F; Kaschka WP; Kircher T; Koller M; Konrad C; Kornhuber J; Krause M; Krug A; Lee M; Leweke M; Lieb K; Mammes M; Meyer-Lindenberg A; Mühlbacher M; Müller MJ; Nieratschker V; Nierste B; Ohle J; Pfennig A; Pieper M; Quade M; Reich-Erkelenz D; Reif A; Reitt M; Reininghaus B; Reininghaus EZ; Riemenschneider M; Rienhoff O; Roser P; Rujescu D; Schennach R; Scherk H; Schmauss M; Schneider F; Schosser A; Schott BH; Schwab SG; Schwanke J; Skrowny D; Spitzer C; Stierl S; Stöckel J; Stübner S; Thiel A; Volz HP; von Hagen M; Walter H; Witt SH; Wobrock T; Zielasek J; Zimmermann J; Zitzelsberger A; Maier W; Falkai PG; Rietschel M; Schulze TG
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):695-701. PubMed ID: 23545941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deprescribing in dermatology: a systematic review of current dermatological guidelines.
    Darr-Foit S; Elsner P; Tittelbach J
    J Dtsch Dermatol Ges; 2019 Mar; 17(3):261-265. PubMed ID: 30758135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [German Society for Psychiatry, Psychotherapy and Psychosomatics (DGPPN) congress 2018-A view to the future].
    Deister A
    Nervenarzt; 2018 Nov; 89(11):1215-1216. PubMed ID: 30310929
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations.
    Langford AV; Lin CC; Bero L; Blyth FM; Doctor J; Holliday S; Jeon YH; Moullin J; Murnion B; Nielsen S; Osman R; Penm J; Reeve E; Reid S; Wale J; Schneider CR; Gnjidic D
    Med J Aust; 2023 Jul; 219(2):80-89. PubMed ID: 37356051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Early recognition and prevention of schizophrenia and other psychoses].
    Meisenzahl E; Walger P; Schmidt SJ; Koutsouleris N; Schultze-Lutter F
    Nervenarzt; 2020 Jan; 91(1):10-17. PubMed ID: 31858162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of pharmacists in deprescribing benzodiazepines: A scoping review.
    Ashkanani FZ; Rathbone AP; Lindsey L
    Explor Res Clin Soc Pharm; 2023 Dec; 12():100328. PubMed ID: 37743854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.
    Radcliffe E; Servin R; Cox N; Lim S; Tan QY; Howard C; Sheikh C; Rutter P; Latter S; Lown M; Brad L; Fraser SDS; Bradbury K; Roberts HC; Saucedo AR; Ibrahim K
    BMC Geriatr; 2023 Sep; 23(1):591. PubMed ID: 37743469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Challenges of deprescribing in the multimorbid patient.
    Cullinan S; Raae Hansen C; Byrne S; O'Mahony D; Kearney P; Sahm L
    Eur J Hosp Pharm; 2017 Jan; 24(1):43-46. PubMed ID: 31156897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [On the legalization debate of non-medical cannabis consumption : Position paper of the German Association for Psychiatry, Psychotherapy and Psychosomatics].
    Havemann-Reinecke U; Hoch E; Preuss UW; Kiefer F; Batra A; Gerlinger G; Hauth I
    Nervenarzt; 2017 Mar; 88(3):291-298. PubMed ID: 27981374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guideline-based quality indicators-a systematic comparison of German and international clinical practice guidelines: protocol for a systematic review.
    Becker M; Breuing J; Nothacker M; Deckert S; Steudtner M; Schmitt J; Neugebauer E; Pieper D
    Syst Rev; 2018 Jan; 7(1):5. PubMed ID: 29329578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guidelines on "pharmacotherapy of neurodegenerative dementia": an update].
    Fassbender K; Frölich L
    Nervenarzt; 2014 Dec; 85(12):1589-600; quiz 1601-2. PubMed ID: 25476188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Resource use and financing of guideline-adherent psychotherapeutic inpatient care].
    Normann C; Wolff J; Hochlehnert A; Klein JP; Hohagen F; Lieb K; Deckert J; Falkai P; Berger M; Herpertz SC
    Nervenarzt; 2015 May; 86(5):534-41. PubMed ID: 25877042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.